COVID-19 Alert Banner
-
Disposable medical face masks required -
Ryan Roberts, MD, PhD. -
Clinical Trials -
Clinical trials: Myths and misconceptions -
Cheryl London - TEDxOhioStateUniversity -
Clinical Trials in Veterinary Medicine
Blue Buffalo Veterinary Clinical Trials Office
- Phone (614) 247-8706
- Fax (614) 247-8428
- CVM-ClinicalTrials@osu.edu
Monday-Friday 8:00am to 5:00pm
New Trials
Evidence exists to suggest that aging of the kidney may contribute to the onset and progression of chronic kidney disease (CKD). Rapamycin is a drug that is a known modulator of the aging process and additionally may decrease the formation of fibrosis (scarring) in the kidney. A feline formulation of the drug is available and the purpose of this study is to assess the potential benefit of the drug in cats with CKD.
This investigation aims to improve the accuracy of the surgical margin assessment in companion animals and improve the accuracy of surgical treatment of canine cancer.
The purpose of the study is to evaluate a new imaging method to detect cancer cells left behind following removal of injection-site sarcomas (FISS) and mammary tumors in cats undergoing surgery.
